202 related articles for article (PubMed ID: 19889480)
1. Designing dendrimers for ocular drug delivery.
Spataro G; Malecaze F; Turrin CO; Soler V; Duhayon C; Elena PP; Majoral JP; Caminade AM
Eur J Med Chem; 2010 Jan; 45(1):326-34. PubMed ID: 19889480
[TBL] [Abstract][Full Text] [Related]
2. Host-guest chemistry of dendrimer-drug complexes. 2. Effects of molecular properties of guests and surface functionalities of dendrimers.
Hu J; Cheng Y; Wu Q; Zhao L; Xu T
J Phys Chem B; 2009 Aug; 113(31):10650-9. PubMed ID: 19603764
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.
Ouyang L; Ma L; Jiang B; Li Y; He D; Guo L
Eur J Med Chem; 2010 Jun; 45(6):2705-11. PubMed ID: 20171762
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
[TBL] [Abstract][Full Text] [Related]
5. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
Cheng Y; Li M; Xu T
Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
7. Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents.
Darbre T; Reymond JL
Acc Chem Res; 2006 Dec; 39(12):925-34. PubMed ID: 17176031
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
Soliman GM; Sharma A; Maysinger D; Kakkar A
Chem Commun (Camb); 2011 Sep; 47(34):9572-87. PubMed ID: 21655634
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications.
Fuchs S; Otto H; Jehle S; Henklein P; Schluter AD
Chem Commun (Camb); 2005 Apr; (14):1830-2. PubMed ID: 15795757
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and supramolecular assembly of clicked anionic dendritic polymers into polyion complex micelles.
Sousa-Herves A; Fernandez-Megia E; Riguera R
Chem Commun (Camb); 2008 Jul; (27):3136-8. PubMed ID: 18594720
[TBL] [Abstract][Full Text] [Related]
11. Improvement of the ocular bioavailability of carteolol by ion pair.
Higashiyama M; Tajika T; Inada K; Ohtori A
J Ocul Pharmacol Ther; 2006 Oct; 22(5):333-9. PubMed ID: 17076627
[TBL] [Abstract][Full Text] [Related]
12. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.
Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914
[TBL] [Abstract][Full Text] [Related]
13. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
14. Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.
Chrisp P; Sorkin EM
Drugs Aging; 1992; 2(1):58-77. PubMed ID: 1554974
[TBL] [Abstract][Full Text] [Related]
15. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
Hu J; Su Y; Zhang H; Xu T; Cheng Y
Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
[TBL] [Abstract][Full Text] [Related]
16. Amine and ammonium functionalization of chloromethylsilane-ended dendrimers. Antimicrobial activity studies.
Ortega P; Copa-Patiño JL; Muñoz-Fernandez MA; Soliveri J; Gomez R; de la Mata FJ
Org Biomol Chem; 2008 Sep; 6(18):3264-9. PubMed ID: 18802631
[TBL] [Abstract][Full Text] [Related]
17. Dendrimers as carriers for delivery of chemotherapeutic agents.
Medina SH; El-Sayed ME
Chem Rev; 2009 Jul; 109(7):3141-57. PubMed ID: 19534493
[No Abstract] [Full Text] [Related]
18. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
Kaneshiro TL; Wang X; Lu ZR
Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
[TBL] [Abstract][Full Text] [Related]
19. Modifications in the chemical structure of Trojan carriers: impact on cargo delivery.
Aussedat B; Dupont E; Sagan S; Joliot A; Lavielle S; Chassaing G; Burlina F
Chem Commun (Camb); 2008 Mar; (12):1398-400. PubMed ID: 18338035
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
